NASDAQ | ETF
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market.
Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 9.18% |
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 8.35% |
NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 5.56% |
0QIU | Novo Nordisk A/S Class B | 5.12% | ||
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 4.42% |
DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 4.01% |
AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 3.85% |
BSX | Boston Scientific Corp | Healthcare | Medical Devices | 3.81% |
SYK | Stryker Corporation | Healthcare | Medical Devices | 3.29% |
SAN | Sanofi SA | Healthcare | Drug Manufacturers - General | 3.24% |
BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 3.13% |
MDT | Medtronic PLC | Healthcare | Medical Devices | 3.12% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.06% |
MCK | McKesson Corporation | Healthcare | Medical Distribution | 3.00% |
TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 2.71% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.69% |
JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 2.42% |
ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.31% |
ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 1.76% |
MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 1.59% |